Skip to content

Participation and compliance rates of prehabilitation program using remot e control

Participation and compliance rates of prehabilitation program using remot e control

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1050230109
Enrollment
54
Registered
2023-10-04
Start date
2023-10-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urology cancer, Lower abdomen cancer, Lung ca ncer, Oral surgery with revascularization Malignancy

Interventions

Exercise Therapy Aerobic exercise (5000 steps/day as prescribed) and resistance exercise (squat, heel lift, front lunge) The videos of resistance exercises (squats, heel lift s, front lunge) will be d
Prehabilitation

Sponsors

Kawaguchi Masahiko
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients aged 65 and over 2) Patients with smartphones 3) Urology cancer patients, Lower abdomen canc er patients, Lung cancer patients, Oral surgery wit h revascularization patients 4) Patients who can secure a period of 14 days or more from the decision to surgery

Exclusion criteria

Exclusion criteria: 1) Patients who don not agree 2) Patients unable to use smartphones 3) Patients unable to walk alone 4) Patients undergoing dialysis 5) Patients undergoing home oxygen therapy 6) Patients visiting a psychiatric clinic 7) Patients with problems eating and swallowing 8) Patients who meet the following cancer rehabilitation discontinuation criteria 1. Blood findings: hemoglobin 7.5g/dl or less, plat elets 50,000ul or less, white blood cells 3,000ul or less 2. Findings of metastasis of long bones with invasi on of 50% or more of the bone cortex, bone erosio n toward the center of the bone, lesions of 3cm or more of the femur, etc. 3. Compression of cavities, blood vessels, and spinal cord 4. Exudate retention in the pleura, peritoneum, an dretroperitoneum due to pain, dyspnea, and restricted movement 5. Central nervous system dysfunction, impaired consciousness, increased intracranial pressure 6. Low/hyperkalemia, low/hypernatremia, low/hypercalcemia 7. Orthostatic hypotension, hypertension of 160/100mmhg or higher 8. Tachycardia of 110/min or more, ventricular arrhythmia

Design outcomes

Primary

MeasureTime frame
Participation and compliance rates

Secondary

MeasureTime frame
Postoperative delirium Postoperative complication Period of hospitalization Grip of hand

Contacts

Public ContactMariko Sato

Nara Medical University

K153699@naramed-u.ac.jp+81-744-29-8902

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026